BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• BioForest

  Howard Dean to Speak at the 2009 Mid-Atlantic Bio Conference

  October 29, 2009

   · 

  3 min read
• OncoMethylome Sciences S.A.: Shareholder Notification

  October 29, 2009

   · 

  1 min read
• Policy

  Stryker Biotech And Its Top Management Indicted For Illegal Promotion Of Medical Devices Used In Invasive Surgeries

  October 29, 2009

   · 

  4 min read
• Policy

  Transcept Pharmaceuticals, Inc. Sleep Drug Denied Approval, Stock Down 48.6% at Market Close

  October 29, 2009

   · 

  6 min read
• Drug Development

  Roche (JOBS), Ipsen (JOBS) Diabetes Drug Meets Late-Stage Target

  October 29, 2009

   · 

  6 min read
• Drug Development

  Forest Laboratories, Inc. (JOBS) and Gedeon Richter Ltd. Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia

  October 29, 2009

   · 

  8 min read
• Job Trends

  ART Advanced Research Technologies Inc. Announces Review of Strategic Options and Downsizing; Company Chops Workforce, Seeks Buyer or Strategic Partners

  October 29, 2009

   · 

  2 min read
• Deals

  Aldagen, Inc. Files for $80.5 Million IPO

  October 29, 2009

   · 

  1 min read
• Business

  Pfizer Inc. (JOBS) Awards Bonuses to Executives for Wyeth (JOBS) Deal

  October 29, 2009

   · 

  1 min read
• Drug Development

  Genta Incorporated Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma, Trial Fails to Meet Primary Endpoint; Stock Down 70.0% at Market Close

  October 29, 2009

   · 

  6 min read